Apax shareholding in Galapagos placed with institutional investors
(Thomson Reuters ONE) -
Mechelen, Belgium; 17 June 2010 - Galapagos NV (Euronext: GLPG) announced that
Kempen and Co. placed nearly 1.3 million Galapagos shares (5.4% of total
outstanding shares) through an accelerated bookbuilding today. These shares
were held by Apax, who obtained their position in Galapagos through the venture
capital financing round in 2002. The shares were placed with European
institutional investors.
"I am very pleased that there is so much institutional investor interest in
Galapagos and that this placement could be executed in only a couple of hours.
We thank Apax for their support as a shareholder over the past eight years and
welcome the new shareholders," said Onno van de Stolpe, CEO of Galapagos.
About Galapagos
Galapagos
biotechnology company specialized in the discovery and development of small
molecule and antibody therapies with novel modes-of-action. The Company is
progressing one of the largest pipelines in biotech, with four clinical and over
50 small molecule discovery/pre-clinical programs. Through risk/reward-sharing
alliances with GlaxoSmithKline, Eli Lilly, Janssen Pharmaceutica, Merck & Co.
and Roche, Galapagos is eligible to receive up to ?3 billion in downstream
milestones, plus royalties. Together with its BioFocus and Argenta service
operations, Galapagos has over 670 employees and operates facilities in six
countries, with global headquarters in Mechelen, Belgium. More info at:
www.glpg.com
CONTACT
Galapagos NV
Onno van de Stolpe, CEO
Tel: +31 6 2909 8028
ir(at)glpg.com
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240
ir(at)glpg.com
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such
forward-looking statements may involve known and unknown risks, uncertainties
and other factors which might cause the actual results, financial condition,
performance or achievements of Galapagos, or industry results, to be materially
different from any historic or future results, financial conditions, performance
or achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
[HUG#1424781]
Unternehmensinformation / Kurzprofil:
Datum: 17.06.2010 - 13:27 Uhr
Sprache: Deutsch
News-ID 22617
Anzahl Zeichen: 0
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 261 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Apax shareholding in Galapagos placed with institutional investors"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
